Institutional investors purchased a net $1.6 million shares of NNVC during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 7.49% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WEALTHTRUST ARIZONA LLC Sold 300.00 shares of NanoViricides Inc
SIMPLEX TRADING LLC Sold 838.00 shares of NanoViricides Inc